A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.

Clinical trial NCT03580005 · WITHDRAWN

Trial details

NCT number: NCT03580005
Sponsor: Pfizer
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder (ADHD)Attention Deficit Hyperactivity Disorder

Start date: 2018-10-31
Primary completion: 2021-10-12
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.